TipRanks
Oramed Pharmaceuticals (IL:ORMP)
TASE:ORMP
Israel Market
ORMP
Oramed Pharm
RESEARCH TOOLSreports

Oramed Pharm (ORMP) Income Statement

1 Followers

Oramed Pharm Income Statement

Last quarter (Q2 2026), Oramed Pharm's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Oramed Pharm's net income was $78.16M. See Oramed Pharm’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Sep 23Dec 22Aug 21
Total Revenue
$ 2.00M$ 0.00$ 1.34M$ 2.70M$ 2.70M
Gross Profit
$ 13.00K$ 0.00$ 1.34M$ 2.70M$ 2.70M
Operating Expenses
$ 15.10M$ 12.78M$ 17.11M$ 43.30M$ 26.93M
Depreciation and Amortization
$ 121.00K$ 193.00K$ 196.00K$ 3.62M$ 77.00K
EBITDA
$ 75.44M$ -14.87M$ 7.32M$ -36.98M$ -24.15M
Operating Income
$ -15.09M$ -12.78M$ -15.77M$ -40.60M$ -24.22M
Other Income/Expenses
$ 90.41M$ -3.14M$ 20.86M$ 2.93M$ 1.23M
Pretax Income
$ 75.32M$ -15.92M$ 5.09M$ -37.66M$ -22.99M
Net Income
$ 64.05M$ -19.06M$ 5.53M$ -37.76M$ -22.24M
Per Share Metrics
Basic EPS
$ 1.53$ -0.48$ 0.14$ -0.97$ -0.78
Diluted EPS
$ 1.50$ -0.48$ 0.14$ -0.97$ -0.78
Weighted Average Shares Outstanding
 41.40M 40.85M 40.32M 39.00M 28.47M
Weighted Average Shares Outstanding (Diluted)
 42.42M 40.85M 40.57M 39.00M 28.47M
Currency in USD

Oramed Pharm Earnings and Revenue History